4/A

OWNERSHIP DOCUMENT

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: April 12, 2023
Period of Report: February 22, 2023
Accession Number: 0001104659-23-044664

View Document ↗ View on SEC.gov ↗